You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 12, September 25, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Critical Care/ Intensive Care Medicine
 •Anemias
 •Hematology, Other
 •Alert me on articles by topic

Red Blood Cell Transfusions in Critically Ill Patients

Paul C. Hébert, MD, MHSc; Dean A. Fergusson, MHA

JAMA. 2002;288:1525-1526.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Transfusions of packed red blood cells (RBCs), a complex biological product prepared from donated blood, are unique in many respects when compared with other health interventions. Despite one of the worst epidemics in recent times being caused, in part, by transfusion of blood products in the 1980s, RBC transfusion remains an essential and frequently performed medical intervention. In the United States, 11.5 million units of blood were donated in 1997.1 Of all units donated yearly, it is estimated that 50% to 70% are transfused in the surgical setting.2-6

In this issue of THE JOURNAL, the international epidemiologic study by Vincent and colleagues7 highlights the frequent use of RBC transfusions in the intensive care unit (ICU). The Anemia and Blood Transfusion in Critical Care (ABC) investigators conducted a cross-sectional study during a 2-week period in November 1999 to evaluate transfusion practices involving . . . [Full Text of this Article]

Author Affiliations: University of Ottawa Centre for Transfusion Research, Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa, Ontario.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anemia, Allogenic Blood Transfusion, and Immunomodulation in the Critically Ill
Raghavan and Marik
Chest 2005;127:295-307.
ABSTRACT | FULL TEXT  

Minimum haemoglobin in intensive care
Desai and Manji
Trauma 2004;6:187-191.
ABSTRACT  

II. When should we transfuse critically ill and perioperative patients with known coronary artery disease?{dagger}
Walsh and McClelland
Br J Anaesth 2003;90:719-722.
FULL TEXT  

The challenge of an increasingly expensive blood system
Wilson and Hebert
CMAJ 2003;168:1149-1150.
FULL TEXT  

Blood Transfusions and Mortality Among Critically Ill Patients
Karkouti et al.
JAMA 2003;289:1242-1242.
FULL TEXT  

Blood Transfusions and Mortality Among Critically Ill Patients
Rathore and Krumholz
JAMA 2003;289:1242-1242.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.